Asdx Biosystems Corporation is categorized under In Vitro Diagnostics in Boulder, CO and active since 2007.
Asdx Biosystems Corporation was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a In Vitro Diagnostics business, which does work in the B2B market, and is classified as a In Vitro Diagnostics, under code number 325413 by the NAICS.
If you are seeking more information, feel free to contact Peter Andreotti at the company’s single location by writing to 5500 Central Avenue # 240, Boulder, Colorado CO 80301 or by phoning (602) 243-3559. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Asdx Biosystems Corporation |
| Contact Person: | Peter Andreotti |
| Address: | 5500 Central Avenue # 240, Boulder, Colorado 80301 |
| Phone Number: | (602) 243-3559 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | In Vitro Diagnostics |
| SIC Code: | 2835 |
| NAICS Code: | 325413 |
| Share This Business: |
Asdx Biosystems Corporation was started in 2007 to provide professional In Vitro Diagnostics under the SIC code 2835 and NAICS code 325413. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Peter Andreotti for inquiries that concern Asdx Biosystems Corporation by calling the company number (602) 243-3559, as your correspondence is most welcome. Additionally, the physical location of the single location of Asdx Biosystems Corporation can be found at the coordinates 40.019438,-105.225075 as well as the street address 5500 Central Avenue # 240 in Boulder, Colorado 80301.
For its online presence, you may visit Asdx Biosystems Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.